Effects of supplementation with fish oil–derived n−3 fatty acids and γ-linolenic acid on circulating plasma lipids and fatty acid profiles in women
Open Access
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 77 (1) , 37-42
- https://doi.org/10.1093/ajcn/77.1.37
Abstract
Background: Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and γ-linolenic acid (GLA) have lipid-modifying and antiinflammatory properties. The effects of supplement mixtures of these fatty acids on plasma lipids and the fatty acid compositions of serum phospholipids have received little attention. Objective: The objective was to determine the effects of different levels of GLA supplementation together with a constant intake of EPA plus DHA on the triacylglycerol-lowering effect of EPA plus DHA alone and on the fatty acid patterns (eicosanoid precursors) of serum phospholipids. Design: Thirty-one women were assigned to 1 of 4 groups, equalized on the basis of their fasting triacylglycerol concentrations. They received supplements providing 4 g EPA+DHA (4:0, EPA+DHA:GLA; control group), 4 g EPA+DHA plus 1 g GLA (4:1), 2 g GLA (4:2), or 4 g GLA (4:4) daily for 28 d. Plasma lipids and fatty acids of serum phospholipids were measured on days 0 and 28. Results: Plasma triacylglycerol concentrations were significantly lower on day 28 than on day 0 in the 4:0, 4:1, and 4:2 groups. LDL cholesterol decreased significantly (by 11.3%) in the 4:2 group. Dihomo-γ-linolenic acid increased significantly in serum phospholipids only in the 4:2 and 4:4 groups; however, total n−3 fatty acids increased in all 4 groups. Conclusions: A mixture of 4 g EPA+DHA and 2 g GLA favorably altered blood lipid and fatty acid profiles in healthy women. On the basis of calculated PROCAM values, the 4:2 group was estimated to have a 43% reduction in the 10-y risk of myocardial infarction.Keywords
This publication has 44 references indexed in Scilit:
- Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management∗∗This article represents one side of a debate on the role of lipid subfractions in cardiovascular risk management; the opposing argument can be found in the accompanying article by Terje R. Pedersen, MD, PhD.The American Journal of Cardiology, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Immunonutrition: the role of ω-3 fatty acidsNutrition, 1998
- Effects of dietary γ-linolenic acid-rich borage oil combined with marine fish oils on tissue phospholipid fatty acid composition and production of prostaglandins E and F of the 1-, 2- and 3-series in a marine fish deficient in Δ5 fatty acyl desaturaseProstaglandins, Leukotrienes & Essential Fatty Acids, 1997
- n-3 Polyunsaturated Fatty Acids and Cytokine Production in Health and DiseaseAnnals of Nutrition and Metabolism, 1997
- Gamma‐linolenic acid treatment of rheumatoid arthritis. A randomized, placebo‐controlled trialArthritis & Rheumatism, 1996
- Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin productionProstaglandins, Leukotrienes & Essential Fatty Acids, 1994
- The effect of dietary fish oil supplement upon the content of dihomo-gammalinolenic acid in human plasma phospholipidsProstaglandins, Leukotrienes & Essential Fatty Acids, 1990
- Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteinsAtherosclerosis, 1989
- Effects of Dietary Supplementation with n‐6 and n‐3 Long‐chain Polyunsaturated Fatty Acids on Serum Lipoproteins and Platelet Function in Hypertriglyceridaemic PatientsActa Medica Scandinavica, 1986